Scientific Program · PDDS 2026

PDDS 2026 — Scientific Program

Day-by-day session and presentation schedule

The full PDDS 2026 scientific program across 3 days — keynotes, oral presentations, and posters. Talks are ordered by program prominence within each day.

Day 1

Day 1

  1. Keynote · Virtual

    Non-crystalline stabilization of iron-oxide nanoparticles enables a versatile platform for carrier-dependent and carrier-free drug delivery

    Lan Wang · Paretor LLC, United States

    We investigated alternative routes for tuning nanoparticle drug-delivery behavior by deliberately disrupting spinel lattice formation during iron-oxide: magnesium synthesis. Under constrained, automation-compatible…

  2. Keynote · Virtual

    Azobenzene-enriched PEG-PLGA micelles as a light-responsive drug delivery platform: Effect of light on biological activity

    Mila Radan · University of Split, Croatia (Hrvatska)

    Azobenzene derivatives have the potential to enable light-induced modulation of biological activity. In this study, azobenzene-enriched PEG-PLGA micelles were developed as a delivery system for a selected anticancer…

  3. Oral · In-Person

    Tailored cellular environments to enable drug design

    Lan Wang · Paretor LLC, United States

    Over the past 50 years, drug delivery has evolved from localized injection to basic pharmacokinetic optimization to targeted intracellular delivery of therapeutics. While these advancements have been critical for…

  4. Oral · In-Person

    Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle

    Lucas Amaral Machado · University of Sao Paulo State – UNESP, Brazil

    Introduction: Pulmonary surfactants in liposomes production became relevant components due to their compatibility with the pulmonary environment. However, the understanding of critical process parameters (CPP) needs to…

  5. Oral · In-Person

    Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety

    Sergey Suchkov · N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation

    Despite breakthroughs in research that have led to an increased understanding of PPM-based human disease, the translation of discoveries into therapies for patients has not kept pace with medical need. Modern drugs are…

  6. Oral

    An injectable CarboCell depot technology for local, sustained dual-antibiotic delivery in bone infections

    Niranjan G Kotla · Technical University of Denmark (DTU), Denmark

    Chronic bone infections remain difficult to treat, as systemic antibiotic therapy often fails to achieve sufficient local drug concentrations in poorly vascularized, infected bone while simultaneously exposing patients…

  7. Oral

    Novel fabrication of adaptive transdermal technologies for drug delivery

    Zeeshan Ahmad · University of Manchester, United Kingdom

    Transdermal drug delivery systems (and technologies) have undergone substantial transformations over the last decade due to advances in 3D Printing, Micromoulding and other novel processing technologies. This…

  8. Oral

    Rational optimization of antibody–cyanine bioconjugates for targeted theranostic drug delivery and photo/sono activation

    Amartya Sanyal · Ariel University, Israel

    Photodynamic therapy (PDT) is a well-established treatment modality; however, its clinical translation is limited by poor light penetration in deep tissues. Sonodynamic therapy (SDT), which utilizes ultrasound as an…

  9. Oral

    Design and characterization of gum arabic buccal films for protein drug delivery

    Krisztian Pamlenyi · University of Szeged, Hungary

    Oral mucoadhesive drug delivery systems, particularly buccal films, have gained increasing attention as promising alternatives to conventional dosage forms. These flexible systems adhere to the oral mucosa for extended…

  10. Oral

    Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties

    Lan Wang · Paretor LLC, United States

    Biocompatible iron oxide nanoparticles (IONPs) are widely used in targeted and responsive delivery, yet conventional formulations adopt crystalline spinel phases that generate magnetic interactions and aggregation…

  11. Oral

    Design and optimization of a nanotechnological platform for future delivery of Sarcomphalus joazeiro (Mart.) extract in dental bleaching

    Lucas Amaral Machado · University of Sao Paulo State – UNESP, Brazil

    Although effective in removing stains from teeth, peroxides can trigger severe side effects, such as gum inflammation and dental hypersensitivity, due to free radical penetration into dentinal tubules. In this scenario…

  12. Oral

    Antibody proteases as translational tools of the next step generation to be applied for biopharmacy related and precision medical practice

    Sergey Suchkov · N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation

    High impact of Ab-proteases is valuable to monitor both clinical and subclinical courses of chronic autoimmune inflammation to predict stepwise transformations of the course, starting from the pre-illness and to…

  13. Oral · In-Person

    Structure-based discovery of kinetic stabilizers for transthyretin amyloidosis

    Salvador Ventura · Universitat Autònoma de Barcelona, Spain

    Transthyretin amyloidosis (ATTR) is a group of fatal protein misfolding disorders caused by the dissociation and aggregation of the transthyretin (TTR) tetramer. Tetramer destabilization, driven by aging or pathogenic…

Day 2

Day 2

  1. Keynote

    From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer

    Vladlen Slepak · University of Miami School of Medicine, United States

    OR51E1 is a G protein-coupled receptor that belongs to the family of olfactory receptors, but is found in a few tissues outside the nasal epithelium. It widely reported as a prostate cancer–associated marker, yet its…

  2. Keynote

    Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems

    Bernd Blobel · University of Regensburg, Germany

    For realizing pervasive and ubiquitous health and social care services, health and social care system have to undergo an organizational, methodological and technological transformation towards personalized…

  3. Keynote

    Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications

    Axel H Schonthal · University of Southern California, United States

    Perillyl alcohol is a naturally occurring monoterpene related to limonene. We have synthesized a clinical-grade version, called NEO100 (NeOnc Technologies, Inc., Los Angeles, California), which has revealed a variety of…

  4. Keynote

    Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry

    Maria Cristina Gamberini · University of Modena and Reggio Emilia, Italy

    Raman and surface-enhanced Raman scattering spectroscopy have become valuable tools in pharmaceutical chemistry because they combine molecular selectivity, limited sample preparation and the possibility of analysing…

  5. Keynote

    Hepatotoxic botanicals-shadows of pearls

    Consolato M Sergi · University of Alberta, Canada

    Objective: The utilization of herbal medicines has risen globally. Recently, the possible adverse effects of certain herbs have been observed, particularly concerning hepatotoxicity associated with the consumption of…

  6. Keynote

    The impact of metal-decorated polymeric nanodots on proton relaxivity

    Paulo Cesar De Morais · Catholic University of Brasilia, Brazil

    The present talk will discuss experimental data regarding successful fabrication of a novel Cu 2+ -complex of nitrogen-rich polymer nanodots, with a mean diameter of about 20 nm extracted from transmission electron…

  7. Keynote

    Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers

    Huiqin Yang · ICON Clinical Research Ltd, United Kingdom

    Diagnosis of lung cancer often occurs in its later disease stage. The prognosis for long term survival for patients with lung cancer is very poor. Early detection of lung cancers can be associated with a reduction in…

  8. Keynote

    Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials

    Luis Jesus Villarreal Gomez · Universidad Autónoma de Baja California, Mexico

    Silk fibroin (SF) and chitosan (CS) are promising biopolymers for biodegradable scaffolds in regenerative therapies. Here, we produced SF/CS composite plugs at 70:30 and 60:40 ratios and compared them to single-polymer…

  9. Keynote · In-Person

    Development and characterization of dual-functional nanofibrous dressing system for burn wound management

    Adrienn Nochta Kazsoki · Semmelweis University, Hungary

    Introduction: Burn wound management remains a considerable clinical challenge, particularly in cases where rapid tissue regeneration, effective infection control, and the prevention of excessive scar formation are…

  10. Keynote · In-Person

    Diabetes risk stratification using self-reported health indicators: A machine learning and explainability approach

    Tanuja Tummala · Harrisburg University of Science and Technology, United States

    This study presents a machine learning approach to classify diabetes status using the CDC BRFSS 2015 dataset, which includes over 250,000 self-reported health records across 22 variables. The goal was to develop a…

  11. Keynote · In-Person

    Cognitivevoice: Novel machine learning model leveraging acoustic features to predict future cognitive decline in Parkinson’s Disease

    Aadya Daga · Hamilton High School, United States

    Parkinson’s Disease (PD) is the second most common neurodegenerative disorder in the world. While it primarily hinders motor functions, PD also causes cognitive dysfunctions which can progress to severe conditions like…

  12. Oral

    R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators

    Adriana Gambardella · Medicine Discovery Catapult, United Kingdom

    The Medicines Discovery Catapult (MDC) is a UK-based national life sciences service, headquartered in Alderley Park, supporting innovators across the full drug discovery and early development pathway through R&D…

  13. Poster

    Characterization, antibacterial, and cytotoxic activities of silver nanoparticles using the whole biofilm layer as a macromolecule in biosynthesis

    Aghapy Yermans Yakoup · Zewail City for Science and Technology, Egypt

    Recently, multi-drug resistant (MDR) bacteria are responsible for a large number of infectious diseases that can be life-threatening. Globally, new approaches are targeted to solve this essential issue. This study aims…

  14. Poster

    Polyphenols as pharmaceutical active ingredients: Current challenges in bioavailability and novel drug delivery

    Roman Lysiuk · Danylo Halytsky Lviv National Medical University, Ukraine

    Plant polyphenols comprise several major classes, including flavonoids, phenolic acids, stilbenes, lignans, and related compounds. Beyond their classical role as antioxidants, they act as pleiotropic modulators of…

  15. Poster

    GC-MS/FID analysis of tea tree oil and development of its nanostructured lipid carriers

    Cemre Irem Ayguler · Acıbadem Mehmet Ali Aydınlar University, Turkey

    Tea tree oil (TTO), derived from Melaleuca alternifolia, exhibits antimicrobial, antifungal, antiviral, and anti-inflammatory properties. However, its effectiveness is limited due to its susceptibility to oxidation…

  16. Poster

    QSAR analysis in drug design: A retrospective, current state, and case studies of mapping structure–activity landscapes of thiazolopyridine-based APIs

    Olena Klenina · Danylo Halytsky Lviv National Medical University, Ukraine

    The development of modern therapeutics relies heavily on Quantitative Structure-Activity Relationship (QSAR) methodologies to guide rational drug design, optimize lead compounds, and minimize empirical trial-and-error.…

  17. Poster

    In silico investigation of thiazolo[4,5-b]pyridine derivatives as potential anti-inflammatory and antioxidant agents

    Olena Klenina · Danylo Halytsky Lviv National Medical University, Ukraine

    This presentation focuses on the design, evaluation, and computational analysis of thiazolo[4,5-b]pyridine-2-one derivatives, with particular emphasis on in silico approaches used to predict their biological activity.…

  18. Poster

    Infant exposure to cannabinoids via the mother’s milk

    Anna W Sobanska · Medical University of Lodz, Poland

    Cannabinoids are the primary active compounds in Cannabis sativa, which has been used for over 4000 years as a recreational drug. The main psychoactive constituent of hemp is Δ9-tetrahydrocannabinol (Δ9-THC). In plants…

  19. Poster

    Evaluation of surface-charged donepezil-loaded liposomes for intranasal nose-to-brain drug delivery

    Elika Valehi · University of Szeged, Hungary

    Intranasal drug administration has gained considerable attention as a non-invasive approach for delivering therapeutic agents directly to the central nervous system (CNS). This route provides the potential to bypass the…

  20. Poster

    Platelet-activating factor-receptor pathway mediates solar radiation-induced extracellular vesicle release in human keratinocytes

    Ravi P Sahu · Wright State University, United States

    Solar ultraviolet (UV) radiation is a major environmental toxicant that contributes to inflammation, immunosuppression, and carcinogenesis. Previous studies suggest that UVB-induced oxidative stress generates oxidized…

  21. Poster

    Artificial Intelligence and digital twins in drug product development: Shaping the future of regulatory science

    Bhasker Sambar · Alvogen Inc, United States

    Background & Rationale: Regulatory agencies including the FDA, EMA, and ICH are increasingly recognizing the value of Artificial Intelligence (AI) and Digital Twin (DT) technologies in pharmaceutical development. FDA's…

Day 3

Day 3

  1. Keynote

    Hydrogen sulfide in sepsis: From bench to bedside

    Madhav Bhatia · University of Otago, New Zealand

    Sepsis is a major health problem worldwide. It is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. Sepsis-related deaths represent 19·7% of deaths from all causes…

  2. Keynote

    From nanoparticles to microneedles: Emerging strategies in skin cancer treatment

    Anil Pareek · Anand Pharmacy College, India

    The incidence rate of skin cancer is very high around the globe, making melanoma and non-melanoma skin cancer serious concerns to the community at large. Current methods used for managing these cancers are limited by…

  3. Keynote

    From in silico docking to in vivo relevance: Predicting drug binding to ligand-bound human serum albumin

    Saad Tayyab · UCSI University, Malaysia

    Binding of drugs to plasma proteins plays a critical role in determining pharmacokinetics, bioavailability, and therapeutic efficacy. Among plasma proteins, Human Serum Albumin is the primary carrier responsible for…

  4. Keynote

    Combinational in silico methods-based screening and selection of druggable targets in certain immune, non-immune and stromal cells in TNBC TME - Lessons for delivery of natural molecules with differentiation potential

    Suresh P.K · VIT University, India

    Based on existing diagnostic data, Breast Cancer (BC) stands second globally and is also a significant contributor to cancer-related deaths in women 1 in several countries including India, necessitating research…

  5. Poster

    A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder

    Kunal Sharma · Swisss Federal Institute of Technology Lausanne, Switzerland

    Conventional antibiotic efficacy metrics fail to capture the mechanopharmacology of bladder infections, where pathogens persist within protected intracellular and subepithelial reservoirs that drive chronic disease. The…

  6. Poster

    From design to activity: Linker flexibility in 3-spiro-2-oxindoline VEGFR-2 inhibitors

    Tarek Aboul Fadl · Assiut University, Egypt

    A series of novel 3-spiro-2-oxindoline derivatives incorporating an aromatic hydrazide linker were rationally designed and synthesized as potential VEGFR-2 inhibitors. This work specifically aimed to evaluate the…

  7. Poster

    Development of a next-generation hepatocyte-targeted nucleic acid delivery platform evading LDLR dependence and PEG-related immunogenicity

    Helen Cho · Samyang Biopharm Corporation, Korea, Republic of

    An effective nucleic acid therapeutic delivery system must ensure consistent performance across both healthy and diseased liver conditions, support repeat dosing without inducing toxicity, and minimize immunogenic…

  8. Poster

    Exploring classical ayurvedic drugs in hypertension

    Prashant Sakharam Bhokardankar · Datta Meghe Ayurvedic Medical College Hospital and Research Centre, India

    Hypertension is a lifestyle disorder. Mostly the disorder is asymptomatic until it gets diagnosed. Hypertension for a longer duration if gets uncontrolled can cause the problems to the eye, kidney blood vessels, and…

  9. Poster

    Formulation, optimization, and in vitro characterization of chitosan–alginate polyelectrolyte complex microbeads incorporated into a natural hydrophilic matrix for extended oral delivery of an antihypertensive drug

    Rama Rao Nadendla · Chalapathi Institute of Pharmaceutical Sciences, India

    Hypertension is a major chronic cardiovascular disorder requiring prolonged pharmacotherapy and consistent maintenance of therapeutic plasma concentrations to achieve optimal clinical outcomes. Conventional…

  10. Poster

    Development of liquid formulations of plasma proteins

    Bhupendra G Prajapati · Parul University, India

    Formulating plasma proteins as liquid dosage forms is challenging due to limited excipients and risks of physical and chemical instability, including aggregation and loss of efficacy. Strategies such as DoE, QbD, and…

  11. Poster

    Pharmaceutical contaminants in the environment: Risk assessment challenges and remediation approaches

    Neha Agarwal · Navyug Kanya Mahavidyalaya, India

    Pharmaceuticals are essential for maintaining human health and have become an indispensable part of modern life. However, their widespread and often uncontrolled use has led to growing concerns about environmental…

  12. Poster

    Structure-based design and smart formulation of stimuli-responsive nanocarriers: Bridging computational docking with advanced drug delivery for targeted therapeutics

    Pradeepa Prasad · The Oxford College of Pharmacy, India

    Oxazolone derivatives have gained significant attention due to their wide spectrum of biological activities, particularly anticancer potential. Breast cancer remains a leading cause of mortality among women…

  13. Poster

    Cannabis therapeutic formulations: SWOT analysis

    Parikshit R Shirode · Parul University, India

    Background: Cannabis has been employed medicinally across nearly all ancient civilizations, with references in the Vedas and classical Ayurvedic texts. Traditionally, it was advocated for acute and chronic pain…

  14. Poster

    Formulation and development of herbal in-situ sustained release otic gel for the treatment of otitis media using Eclipta alba

    Dev Soni · Shree Swaminarayan Sanskar Pharmacy College, India

    Otitis media remains one of the most common ear infections in young children, and conventional otic formulations often suffer from short residence time and rapid drainage from the ear canal, limiting therapeutic…

  15. Poster

    Development of arteether nanoemulsion for improved oral bioavailability and antimalarial efficacy against Plasmodium yoelii nigeriensis

    Priyanka Chaturvedi · Jai Narain College of Pharmacy, JNCTPU, India

    Background: Arteether (ART) is a potent antimalarial drug, but its clinical utility is limited due to low aqueous solubility and poor oral bioavailability. This study aimed to develop an ART-loaded nanoemulsion (ART-NE)…

  16. Poster

    Fabrication, characterization, and evaluation of pyrazinamide-loaded immediate-release tablets via fused deposition modeling 3D printing for personalized tuberculosis treatment

    Shubham Singh · Maharaja Ranjit Singh Punjab Technical University, India

    Purpose: Paediatric tuberculosis (TB) treatment is challenged by the need for age-appropriate dosage forms, flexible dose adjustment, and improved patient adherence. Three-dimensional (3D) printing has become an…

  17. Poster

    Nanotechnology in pharmaceutics and drug delivery systems: A medicinal mathematics perspective

    Vishwa Mehul Patel · Shri Swaminarayan Institute, India

    Nanotechnology has emerged as a transformative approach in pharmaceutics and drug delivery systems, enabling precise targeting, controlled drug release, and improved bioavailability of therapeutic agents. This…

Present your research at PDDS 2027

Abstract submissions for the 2027 program are open · September 13–15, 2027 · Olympia Hotel, Events & Spa, Valencia, Spain.

Submit Abstract →

Join the PDDS 2027 delegation

Valencia · September 13–15, 2027 · Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.